These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38903381)

  • 1. Estimating the Economic Impact of Levalbuterol's Potential Transition From the National Reimbursement Drug List for the Treatment of Pediatric Asthma in China: A Budget Impact Analysis.
    Tang T; Lin C; Zhi C; Li X; Wu Y
    Cureus; 2024 May; 16(5):e60640. PubMed ID: 38903381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levalbuterol
    Chen L; Chen X; Zhi C; Li X; Hu Y
    J Med Econ; 2022; 25(1):966-973. PubMed ID: 35786135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis.
    Zhang D; Li X; Ding J; Ke X; Ding W; Ren Y; Xu H; Li H; Ma A; Tang W
    Front Public Health; 2021; 9():670108. PubMed ID: 34295868
    [No Abstract]   [Full Text] [Related]  

  • 5. Levalbuterol versus albuterol.
    Ameredes BT; Calhoun WJ
    Curr Allergy Asthma Rep; 2009 Sep; 9(5):401-9. PubMed ID: 19671384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budgetary Impact of Cabazitaxel Use After Docetaxel Treatment for Metastatic Castration-Resistant Prostate Cancer.
    Flannery K; Drea E; Hudspeth L; Corman S; Gao X; Xue M; Miao R
    J Manag Care Spec Pharm; 2017 Apr; 23(4):416-426. PubMed ID: 28345444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis.
    Xu X; Bao Y; Xu K; Zhang Z; Zhao N; Li X
    Front Public Health; 2022; 10():913129. PubMed ID: 35903377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of levalbuterol to a pediatric emergency department automated medication management system does not increase its use.
    Conners GP; Hays DP; Richardson T; Zwemer FL
    Int J Emerg Med; 2009 Dec; 2(4):251-4. PubMed ID: 20436896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the Length of Stay and Economic Impact of Albuterol and Levalbuterol in Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.
    Liu X; Zhang H; Yang Z; Ran Y; Qiu Y; Wang L; Zeng L; Li X; Zhi C; Lu J
    Cureus; 2024 Apr; 16(4):e59039. PubMed ID: 38803713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective.
    Xu X; Schaefer C; Szende A; Genofre E; Katial R; Chung Y
    J Manag Care Spec Pharm; 2023 Nov; 29(11):1193-1204. PubMed ID: 37796731
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore.
    Boisseau S; Qasuri M; Ho WT; Ghosh W; Hadjiat Y
    Clinicoecon Outcomes Res; 2020; 12():567-577. PubMed ID: 33116696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma.
    Truitt T; Witko J; Halpern M
    Chest; 2003 Jan; 123(1):128-35. PubMed ID: 12527613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic impact analysis of a minimally invasive temperature-controlled radiofrequency device versus nasal surgery for the treatment of nasal airway obstruction in the United States.
    Yong M; Hollemon D; Baxter J; Hirst A; Bryning S; Fox A; Smith G; Hughes R; Brandolini G; Wolf S; Ow R
    J Med Econ; 2024; 27(1):708-714. PubMed ID: 38581156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt.
    Elsisi GH; Carapinha J; Amin W; Thabet E; Elafify S; Amin M; Hatem A
    J Med Econ; 2019 Oct; 22(10):1047-1054. PubMed ID: 31298593
    [No Abstract]   [Full Text] [Related]  

  • 15. A patient satisfaction survey comparing levalbuterol with racemic albuterol in children.
    Berger WE; Ames DE; Harrison D
    Allergy Asthma Proc; 2004; 25(6):437-44. PubMed ID: 15709455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
    Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
    Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.